Bay area companies are one step ahead in the exploding field of stem cell research. The counties of San Francisco, San Mateo and San Diego, along with the cities of Boston and Madison, Wis., have become major hubs of the nation’s fast-growing biotechnology sector, which includes companies working on stem cells and other areas of regenerative medicine.
Eight year old girl Pratima Aich from Dum Dum, Kolkata, who was suffering from neuroblastoma, a type of abdominal cancer, under went an autologus bone marrow stem cell transplantation at Kolkata.
According to the current issue of CELL TRANSPLANTATION the researchers of The university of Florida has discovered a preliminary “molecular signature” based on gene expression. This will help them to predict acute GVHD (graft-versus-host disease) and will also improve the output of liver stem cell transplant. This development is supposed to be a major breakthrough.
On 11th July 2008, Stempeutics Research Private Limited, a group company of Manipal Education and Medical Group(MEMG) opened its second Stem Cell Lab at Manipal University campus.Chief Scientific Officer of Stempeutics Dr Satish Totey, Vice-Chancellor of MU Dr Raj P Warrier, General Manager of Stempeutics N Manjunath and others were present in that auspicious occasion.
HepaLife Technologies, Inc., announces the development of two new derivative cell lines which can be used for the treatment of human liver failure. This stem cell lines will be used in Hepalife’s first -of-its-kind Bio artificial liver device which is currently under development phase.
A bowed tendon used to mean the end of a racehorse’s career. Now, as The Scientist magazine reports, the injury can be recovered with a novel stem cell treatment derived from the horse’s own cells.
Greg’s Gold earned over $1,000,000 during his career despite suffering a “career ending” bowed
tendon in 2005. He was able to recover and continue racing thanks to the stem cell treatment at Vet-Stem.
Full article »
Recent research has developed a new way of treating liver failure that could save the lives of thousands of patients on transplant waiting lists.
Full article »